14 — Vitamin C and Endogenous Oxalate: When Supplementation Changes Metabolic Exposure
Series: The Oxalate–Brain Hypothesis
Evidence class: Documented biochemical conversion and case-associated nephropathy

Abstract
Ascorbic acid can be metabolized to oxalate. Under many circumstances this contribution is clinically modest, but unusually high intake, kidney impairment or malabsorptive disease can change the risk calculation. Reports of oxalate nephropathy associated with high-dose vitamin C illustrate how an ostensibly beneficial intervention may add metabolic burden in a susceptible host. Claims that this causes psychiatric disease remain speculative.

The dose problem
Vitamin C is essential for human physiology; it is not inherently a toxin. Its breakdown can nevertheless contribute to oxalate formation, particularly at high exposures. The amount converted and excreted varies with dose, route, kidney function and other host factors. Clinical case reports, including one involving high vitamin C exposure combined with pancreatic insufficiency, document the possibility of clinically important renal oxalate deposition. A case report demonstrates possibility in a specific setting, not prevalence across ordinary supplement users.

Two simultaneous causes
When an individual has both excess precursor availability and increased intestinal oxalate absorption, there may be contributions from more than one route. In pancreatic insufficiency, fat malabsorption alters intestinal binding, while vitamin C can add endogenous oxalate. Renal clearance then determines how long metabolites persist. The relevant object of treatment is the pathway actually causing injury, not the abstract category “vitamin toxicity.” Other causes of acute kidney injury must also be considered.

A neuropsychiatric hypothesis
If substantial oxalate nephropathy led to metabolic encephalopathy, vitamin C might be implicated as one upstream exposure. But a patient taking vitamin C who reports low mood cannot be presumed to have oxalate-mediated neural injury. Direct evidence of kidney impairment or another credible biochemical intermediary would be essential. In studies claiming psychiatric benefits from restricting vitamin C, changes in illness, diet, other supplements and expectation would be serious confounders.

Practical intellectual lesson
This is a useful antidote to the idea that nutrients have purely beneficial effects independent of dose and host state. It equally rejects the opposite claim that any dose of a substance with a toxic metabolic product is unsafe. A rigorous model makes its exposure scale explicit and defines vulnerability rather than converting rare events into blanket dietary warnings.

Conclusion
Oxalate formation from ascorbate is a real metabolic route with documented relevance in some renal injury cases. There is no convincing basis for asserting that routine vitamin C intake causes psychosis, depression or autism through oxalate.

Selected readings
- Fijen and Weijmer, Acute oxalate nephropathy due to high vitamin C doses and pancreatic insufficiency: https://pmc.ncbi.nlm.nih.gov/articles/PMC6887424/
- Treatment of primary hyperoxaluria type 1: https://pmc.ncbi.nlm.nih.gov/articles/PMC9113429/